| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 464.099 | 472.180 | 456.127 | 552.295 | 534.476 | 501.300 | 684.301 | 788.942 | 918.225 | 829.157 |
| Total Income - EUR | 464.201 | 476.230 | 464.093 | 552.591 | 537.378 | 501.316 | 685.138 | 790.578 | 918.885 | 830.724 |
| Total Expenses - EUR | 463.256 | 460.672 | 459.055 | 593.105 | 534.463 | 481.148 | 648.265 | 683.790 | 772.040 | 808.254 |
| Gross Profit/Loss - EUR | 944 | 15.557 | 5.038 | -40.514 | 2.915 | 20.168 | 36.873 | 106.788 | 146.845 | 22.470 |
| Net Profit/Loss - EUR | 944 | 15.557 | 525 | -40.830 | 2.397 | 16.908 | 30.750 | 89.492 | 134.469 | 18.401 |
| Employees | 8 | 8 | 10 | 2 | 5 | 8 | 8 | 6 | 6 | 6 |
Check the financial reports for the company - Dalex Doc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 86.033 | 102.056 | 82.255 | 114.314 | 96.570 | 101.154 | 101.732 | 137.701 | 165.408 | 222.519 |
| Current Assets | 37.880 | 51.903 | 63.751 | 26.872 | 45.470 | 9.239 | 32.895 | 55.154 | 57.158 | 214.539 |
| Inventories | 24.782 | 31.893 | 55.280 | 10.615 | 17.705 | 3.014 | 28.208 | 22.972 | 36.880 | 50.452 |
| Receivables | 13.002 | 16.028 | 8.301 | 14.044 | 24.496 | 5.140 | 3.605 | 22.115 | 16.068 | 162.144 |
| Cash | 96 | 3.983 | 170 | 2.213 | 3.269 | 1.085 | 1.082 | 10.067 | 4.210 | 1.943 |
| Shareholders Funds | -46.119 | -30.092 | -50.010 | -89.922 | -85.784 | -67.250 | -35.008 | 54.376 | 24.972 | 43.233 |
| Social Capital | 1.170 | 1.158 | 10.989 | 10.788 | 10.579 | 10.378 | 10.148 | 10.179 | 10.149 | 10.092 |
| Debts | 195.354 | 210.582 | 246.270 | 250.364 | 228.771 | 177.642 | 169.635 | 138.480 | 197.594 | 393.824 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4636 - 4636" | |||||||||
| CAEN Financial Year |
4721
|
|||||||||
Comments - Dalex Doc S.r.l.